African Programe for Training in HIV/TB Research

非洲艾滋病毒/结核病研究培训计划

• 批准号: 7248031
• 负责人: PETER R MASON
• 金额: $ 38.66万
• 依托单位: BIOMEDICAL RESEARCH & TRAINING INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-28 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7248031
• 关键词: Achievement; Acquired Immunodeficiency Syndrome; Address; Affect; Africa; Africa South of the Sahara; African; Ally; Anti-Retroviral Agents; Area; Award; Basic Science; Biomedical Research; Books; Caring; Certification; Class; Clinical; Clinical Research; Clinical Skills; Clinical Trials; Collaborations; Colorado; Communication; Communities; Country; Developed Countries; Developing Countries; Development; Discipline; Distance Education; Distance Learning; Economics; Educational process of instructing; Electronic Mail; Epidemic; Epidemiology; Ethics; Evaluation; Faculty; Fees; Financial Support; Future; Grant; HIV; Health Priorities; Health Professional; Health Sciences; Health Services; Health Services Research; Health system; Healthcare; Hospitals; Human Resources; Infant; Infection; Institutes; Institution; International; Internet; Laboratories; Laboratory Study; Life; Life Expectancy; Literature; Mentors; Mycobacterium tuberculosis; Opportunistic Infections; Pediatric Hospitals; Phase; Physicians; Postdoctoral Fellow; Prevention; Prevention program; Reporting; Research; Research Methodology; Research Personnel; Research Project Grants; Research Training; Resources; Science; Scientist; Southern Africa; Students; Technology; Testing; Training; Training Programs; Training and Education; Translational Research; Tuberculosis; Universities; Week; Zimbabwe; base; career; cohort; continuing medical education; cost; design; experience; field study; improved; medical schools; payment; programs; research study; response; skills; tool; treatment program

DESCRIPTION (provided by applicant): The burden of HIV and opportunistic infections (Ol), particularly Mycobacterium tuberculosis (TB) are profoundly eroding infant survival, life expectancy, the economy and health care in Sub-Saharan Africa. Clinical, operational and translational research are recognized as essential responses to the epidemic. However, resource constraints, economic and health priorities limit capacity to train effective investigators and scientists. Research training and increased opportunities for researchers to develop internationally competitive skills are essential for effective responses to the HIV and TB epidemics. The proposed ICOHRTA collaboration between the Biomedical and Research Training Institute (BRTI), University of Zimbabwe (UZ) and Stanford University will provide clinical, laboratory, epidemiological, statistical and operational research training in an academic framework. The primary aim is to enable young African scientists to improve their research capacity: to design, implement and report on meaningful and relevant research. In collaboration with current clinical trials in HIV and TB prevention and treatment, the program will provide three critical areas of training: 1) Support and attachment of students to active clinical and laboratory research projects in Zimbabwe including field, laboratory, clinical, operational and health systems' delivery studies focused on prevention and treatment of HIV, TB, and Ol. 2) For post-graduate clinicians, a 2-year mentored clinical experience in HIV, TB and opportunistic infections and the opportunity for practical clinical experience in HIV clinical trials, prevention and care at Stanford University, the University of Colorado, the Children's Hospital of Oakland, and other US-medical schools and hospitals. 3) Training and experience in research for post-doctoral fellows from the US who will participate in the BRTI short-training courses as part of ongoing, substantial mentored clinical research with US and UZ faculty-investigators. To increase access to literature and developments in treatment and prevention, the program will develop, test and evaluate internet-based training and teaching tools to access interactive courses and training in good clinical practice, epidemiology, basic science, ethics, and translational research on the web. The aim is to equip students in the health sciences and young clinicians from Zimbabwe and the US to meet the challenges of these devastating epidemics through robust training in research methods and participation in clinical trials, operational and laboratory studies in Zimbabwe.

描述（由申请人提供）： 艾滋病毒和机会性感染 (Ol)，特别是结核分枝杆菌 (TB) 的负担正在严重损害撒哈拉以南非洲地区的婴儿存活率、预期寿命、经济和医疗保健。临床、操作和转化研究被认为是应对这一流行病的重要对策。然而，资源限制、经济和卫生优先事项限制了培训有效的研究人员和科学家的能力。研究培训和增加研究人员发展国际竞争力技能的机会对于有效应对艾滋病毒和结核病流行至关重要。生物医学和研究培训机构 (BRTI)、津巴布韦大学 (UZ) 和斯坦福大学之间拟议的 ICOHRTA 合作将在学术框架内提供临床、实验室、流行病学、统计和业务研究培训。主要目标是使年轻的非洲科学家能够提高他们的研究能力：设计、实施和报告有意义和相关的研究。该计划将与当前艾滋病毒和结核病预防和治疗的临床试验合作，提供三个关键领域的培训： 1) 支持和参与津巴布韦活跃的临床和实验室研究项目 包括现场、实验室、临床、运营和卫生系统的交付研究，重点是艾滋病毒、结核病和结核病的预防和治疗。 2) 对于研究生临床医生，具有 2 年 HIV、TB 和机会性临床指导经验 感染以及在艾滋病毒临床试验、预防和治疗方面获得实际临床经验的机会 斯坦福大学、科罗拉多大学、奥克兰儿童医院等机构的护理 美国医学院和医院。 3) 参加美国博士后的培训和研究经验 BRTI 短期培训课程是与美国和美国正在进行的、大量指导临床研究的一部分 UZ 教师研究员。为了增加获取文献和治疗和预防进展的机会，该计划将开发、测试和评估基于互联网的培训和教学工具，以获取良好临床实践、流行病学、基础科学、伦理学和转化研究方面的互动课程和培训。网络。其目的是让来自津巴布韦和美国的健康科学学生和年轻临床医生通过研究方法方面的强有力培训以及参与津巴布韦的临床试验、操作和实验室研究来应对这些毁灭性流行病的挑战。